Nexalin Technology (NXL) Operating Expenses (2021 - 2026)

Nexalin Technology has reported Operating Expenses for 6 years, with the latest figure at $2.3 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 35.22% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $9.3 million, a 1.96% increase from a year earlier, with the FY2025 full-year figure at $8.6 million, up 9.44% from the prior year.
• Operating Expenses was $2.3 million for Q2 2026 at Nexalin Technology, up from $2.1 million in the prior quarter.
• The five-year high for Operating Expenses was $2.9 million in Q4 2024, with the low at $651219.0 in Q3 2022.
• Average Operating Expenses over 5 years is $1.6 million, with a median of $1.7 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses slumped 64.65% in 2022, then jumped 274.02% in 2023.
• Over 5 years, Operating Expenses stood at $751174.0 in 2022, then soared by 118.3% to $1.6 million in 2023, then jumped by 76.55% to $2.9 million in 2024, then declined by 11.43% to $2.6 million in 2025, then retreated by 12.01% to $2.3 million in 2026.
• The last three Operating Expenses figures came in at $2.3 million (Q2 2026), $2.1 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.